131 related articles for article (PubMed ID: 25917031)
1. [Desmosine plasma levels and exacerbation risk assessment of chronic obstructive pulmonary disease].
Yang Y; Guo Y; Zhang H; Sun T
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(8):577-80. PubMed ID: 25917031
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptide LL-37 circulating levels in chronic obstructive pulmonary disease patients with high risk of frequent exacerbations.
Yang YM; Guo YF; Zhang HS; Sun TY
J Thorac Dis; 2015 Apr; 7(4):740-5. PubMed ID: 25973241
[TBL] [Abstract][Full Text] [Related]
3. High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers.
Ko HK; Hsu WH; Hsieh CC; Lien TC; Lee TS; Kou YR
Respirology; 2014 Feb; 19(2):253-261. PubMed ID: 24372740
[TBL] [Abstract][Full Text] [Related]
4. Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease.
Huang JT; Chaudhuri R; Albarbarawi O; Barton A; Grierson C; Rauchhaus P; Weir CJ; Messow M; Stevens N; McSharry C; Feuerstein G; Mukhopadhyay S; Brady J; Palmer CN; Miller D; Thomson NC
Thorax; 2012 Jun; 67(6):502-8. PubMed ID: 22250098
[TBL] [Abstract][Full Text] [Related]
5. Urinary desmosine is associated with emphysema severity and frequent exacerbation in patients with COPD.
Kim C; Ko Y; Kim SH; Yoo HJ; Lee JS; Rhee CK; Lee JH; Lee JH; Kim TH; Lim SY; Yoo KH; Seo JB; Oh YM; Lee SD; Park YB
Respirology; 2018 Feb; 23(2):176-181. PubMed ID: 28905464
[TBL] [Abstract][Full Text] [Related]
6. Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD.
Rabinovich RA; Miller BE; Wrobel K; Ranjit K; Williams MC; Drost E; Edwards LD; Lomas DA; Rennard SI; Agustí A; Tal-Singer R; Vestbo J; Wouters EF; John M; van Beek EJ; Murchison JT; Bolton CE; MacNee W; Huang JT;
Eur Respir J; 2016 May; 47(5):1365-73. PubMed ID: 27009168
[TBL] [Abstract][Full Text] [Related]
7. Association of plasma netrin-1 level with inflammatory balance and comorbidities in patients with acute exacerbation of COPD.
Kerget B; Afşin DE; Kerget F; Koçak AO; Aksakal A; Kızıltunç A; Araz Ö; Yılmazel Uçar E; Akgün M
Tuberk Toraks; 2021 Mar; 69(1):30-38. PubMed ID: 33853303
[TBL] [Abstract][Full Text] [Related]
8. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
9. [The correlation of vitamin D level and vitamin D-binding protein gene polymorphism in chronic obstructive pulmonary disease].
Li X; Liu X; Xu Y; Xiong W; Zhao J; Ni W; Chen S
Zhonghua Nei Ke Za Zhi; 2014 Apr; 53(4):303-7. PubMed ID: 24857306
[TBL] [Abstract][Full Text] [Related]
10. Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD.
Wei X; Ma Z; Yu N; Ren J; Jin C; Mi J; Shi M; Tian L; Gao Y; Guo Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():121-129. PubMed ID: 29343951
[TBL] [Abstract][Full Text] [Related]
11. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
Rahman I; Swarska E; Henry M; Stolk J; MacNee W
Thorax; 2000 Mar; 55(3):189-93. PubMed ID: 10679536
[TBL] [Abstract][Full Text] [Related]
12. [An enzyme-linked immunosorbent assay for measuring desmosine in vivo].
Nishimura K
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Dec; 27(12):1502-8. PubMed ID: 2630771
[TBL] [Abstract][Full Text] [Related]
13. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
[TBL] [Abstract][Full Text] [Related]
14. A2M Serves as Promising Biomarker for Chronic Obstructive Pulmonary Disease.
Xiao X; Cai W; Ding Z; Shi Y; Fan L; Zhang Q
Int J Chron Obstruct Pulmon Dis; 2023; 18():683-692. PubMed ID: 37123074
[TBL] [Abstract][Full Text] [Related]
15. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
Liu H; Xu JY
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
[TBL] [Abstract][Full Text] [Related]
16. Anti-
Banerjee S; Bhattacharyya P; Mitra S; Kundu S; Panda S; Chatterjee IB
Int J Chron Obstruct Pulmon Dis; 2017; 12():1847-1856. PubMed ID: 28684907
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
[TBL] [Abstract][Full Text] [Related]
18. Complement factor C5a in acute exacerbation of Chronic Obstructive Pulmonary Disease.
Marc MM; Kristan SS; Rozman A; Kern I; Flezar M; Kosnik M; Korosec P
Scand J Immunol; 2010 May; 71(5):386-91. PubMed ID: 20500690
[TBL] [Abstract][Full Text] [Related]
19. Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report.
Fiorenza D; Viglio S; Lupi A; Baccheschi J; Tinelli C; Trisolini R; Iadarola R; Luisetti M; Snider GL
Respir Med; 2002 Feb; 96(2):110-4. PubMed ID: 11860167
[TBL] [Abstract][Full Text] [Related]
20. Small airway immunoglobulin A profile in emphysema-predominant chronic obstructive pulmonary disease.
Liu H; Tang HY; Xu JY; Pang ZG
Chin Med J (Engl); 2020 Aug; 133(16):1915-1921. PubMed ID: 32826454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
